510(k) K190397

Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA by Immunalysis Corporation — Product Code QBK

K190397 is an FDA 510(k) premarket notification submitted by Immunalysis Corporation for the device "Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA". The FDA issued a decision of Substantially Equivalent on Nov 15, 2019. The device falls under product code QBK (Meprobamate Test System), a Class II device regulated under 21 CFR 862.3590. Immunalysis Corporation has 49 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Nov 15, 2019
Date Received
Feb 19, 2019
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Meprobamate Test System
Device Class
Class II
Regulation Number
862.3590
Review Panel
TX
Submission Type
510(k)

A meprobamate test system is a device intended to measure meprobamate in human specimens. Measurements obtained by this device are used to detect the presence of meprobamate to diagnose the use or overdose of meprobamate or structurally-related drug compounds (e.g., prodrugs).

Need the full FDA record for Immunalysis Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K190397. Report a data issue: hello@regdatalab.com.